A clinical trial suggests that a high-fiber, plant-based diet may delay precursor conditions leading to multiple myeloma, a prevalent blood cancer.
The diet intervention showed improvements in metabolic, immunologic, and microbiome biomarkers, offering new avenues for cancer prevention.
Addressing obesity, poor diets, and gut microbiota dysbiosis is crucial for preventing the progression to myeloma.
The study emphasizes the importance of dietary quality in early disease stages and the potential of diet in altering disease trajectory.
Participants in the study showed significant improvements in BMI, disease progression metrics, insulin resistance, and gut microbiota diversity.
The prescribed plant-based diet led to a notable increase in fiber intake and sustained dietary behavior change among participants.
The research suggests that dietary patterns could reduce risks of cancer, cardiovascular disease, and other metabolic syndromes.
Incremental dietary changes to increase fiber intake can have broad health benefits and reduce cancer risk.
The study's findings support the role of dietary modulation in cancer prevention and ongoing research is exploring diet's impact on gut microbiome and hematologic disorders.
While preliminary, these results indicate a paradigm shift towards using plant-based, fiber-rich nutrition for preventive oncology.